<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="EN" article-type="research-article">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Lab Anim Res</journal-id>
<journal-id journal-id-type="publisher-id">LAR</journal-id>
<journal-title-group>
<journal-title>Laboratory Animal Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1738-6055</issn>
<issn pub-type="epub">2233-7660</issn>
<publisher>
<publisher-name>Korean Association for Laboratory Animal Science</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.5625/lar.2017.33.4.308</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Quercetin attenuates the injury-induced reduction of &#x03B3;-enolase expression in a middle cerebral artery occlusion animal model</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Jeon</surname>
<given-names>Seong-Jun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Myeong-Ok</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Ali-Shah</surname>
<given-names>Fawad</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Koh</surname>
<given-names>Phil-Ok</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

</contrib-group>

<aff id="A1"><label>1</label>Department of Anatomy, College of Veterinary Medicine, Research Institute of Life Science, Gyeongsang National University, 501 Jinju-daero, Jinju 660-701, South Korea.</aff>
<aff id="A2"><label>2</label>Division of Life Science and Applied Life Science, College of Natural Sciences, Gyeongsang National University, 501 Jinju-daero, Jinju 660-701, South Korea.</aff>

<author-notes>
<corresp>Corresponding author: Phil-Ok Koh, Department of Anatomy, College of Veterinary Medicine, Gyeongsang National University, 501 Jinju-daero, Jinju 52828, South Korea. Tel: +82-55-772-2354; Fax: +82-55-772-2349; <email>pokoh@gnu.ac.kr</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>33</volume>
<issue>4</issue>
<fpage>308</fpage>
<lpage>314</lpage>

<history>
<date date-type="received">
<day>27</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>07</day>
<month>01</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>01</month>
<year>2018</year>
</date>
</history>

<permissions>
<copyright-statement>Copyright &#x00A9; 2017 Korean Association for Laboratory Animal Science</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Korean Association for Laboratory Animal Science</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<p>Quercetin, a natural flavonoid, copiously exists in vegetable, fruits and tea. Quercetin is beneficial to neurodegenerative disorders via its strong anti-oxidant and anti-inflammatory activities. &#x03B3;-Enolase is one of the enzymes of glycolytic pathway and is predominantly expressed in neuronal cells. The aim of the present study is to verify whether quercetin modulates the expression of &#x03B3;-enolase in brain ischemic injury. Adult Sprague-Dawley male rats were subjected to middle cerebral artery occlusion (MCAO) and quercetin (50 mg/kg) or vehicle was administered by intraperitoneal injection at 1 h before MCAO onset. A proteomics study, Western blot analysis, reversetranscription-PCR, and immunofluorescence staining were conducted to investigate the change of &#x03B3;-enolase expression level. We identified a decline in &#x03B3;-enolase expression in MCAO-operated animal model using a proteomic approach. However, quercetin treatment significantly attenuated this decline. These results were confirmed using Western blot analysis, reverse transcription-PCR, and immunofluorescence staining techniques. &#x03B3;-Enolase is accepted as a neuron specific energy synthesis enzyme, and quercetin modulates &#x03B3;-enolase in a MCAO animal model. Thus, our findings can suggest the possibility that quercetin regulates &#x03B3;-enolase expression in response to cerebral ischemia, which likely contributes to the neuroprotective effect of quercetin.</p>
</abstract>

<kwd-group>
<kwd>cerebral ischemia</kwd>
<kwd>neuroprotection</kwd>
<kwd>quercetin</kwd>
</kwd-group>

<funding-group>

<award-group>
<funding-source country="KR">
<institution-wrap>
<institution>National Research Foundation of Korea</institution>
<institution-id institution-id-type="CrossRef">http://dx.doi.org/10.13039/501100003725</institution-id>
</institution-wrap>
</funding-source>
<award-id>NRF-2015R1D1A1A01058270</award-id>
</award-group>

</funding-group>

</article-meta>
</front>

<body>

<p>Quercetin (3,5,7,30,40-pentahydroxyflavone) is a natural flavonoid that abundantly exists in vegetable, fruits and tea. It is reported that natural flavonoid is beneficial to many disorders such as neurodegenerative disorders, diabetes, and cancer via its strong anti-oxidant and anti-inflammatory activities [<xref ref-type="bibr" rid="B1">1</xref><xref ref-type="bibr" rid="B2">2</xref>]. It is well known that oxidative stress increases neuronal cell membrane breakdown [<xref ref-type="bibr" rid="B3">3</xref>]. Quercetin effectively protects the neuronal cells from the oxidative stress-induced neurodegeneration, decreases lipid peroxidation, prevents glutathione depletion, and improves the activity of catalase and superoxide dismutase [<xref ref-type="bibr" rid="B4">4</xref><xref ref-type="bibr" rid="B5">5</xref><xref ref-type="bibr" rid="B6">6</xref>]. Quercetin conserves neurons against oxidative stress and excitotoxicity by the modulation of cell death mechanisms [<xref ref-type="bibr" rid="B7">7</xref>]. Moreover, quercetin reduces apoptotic cell death in brain tissue of focal cerebral ischemia through the activation of brain derived neurotrophic factor and phosphoinositide 3 kinase (PI3K)/Akt signaling pathway [<xref ref-type="bibr" rid="B8">8</xref>].</p>

<p>Enolases are categorized as a glycolytic enzyme that participates in various cellular activities such as growth and differentiation [<xref ref-type="bibr" rid="B9">9</xref>]. Several functions are designated to the different isoforms of enolases according to their cellular localization. &#x03B1;-Enolase form occurs ubiquitously in most cells including macrophages and glial cells [<xref ref-type="bibr" rid="B10">10</xref><xref ref-type="bibr" rid="B11">11</xref>]. &#x03B2;-Enolase exists in non-neuronal cells and is expressed exclusively in muscle cells [<xref ref-type="bibr" rid="B12">12</xref>]. &#x03B3;-Enolase presents with its abundance in mature neurons and neuroendocrine cells, and so called neuronal specific enolase [<xref ref-type="bibr" rid="B13">13</xref>]. Also, &#x03B3;-enolase is present in dendrites and amine precursor uptake and decarboxylation cells [<xref ref-type="bibr" rid="B14">14</xref>]. &#x03B3;-Enolase is released to extracellular space from cells in destruction of neuronal cell membrane by injurious factor [<xref ref-type="bibr" rid="B15">15</xref><xref ref-type="bibr" rid="B16">16</xref><xref ref-type="bibr" rid="B17">17</xref>]. Moreover, it is accepted as a biomarker related with brain diseases such as traumatic brain injury, stroke, hypoxic encephalopathy and epileptic seizure [<xref ref-type="bibr" rid="B15">15</xref><xref ref-type="bibr" rid="B16">16</xref><xref ref-type="bibr" rid="B18">18</xref><xref ref-type="bibr" rid="B19">19</xref>]. Therefore, we designed the experiments based on the hypothesis that ischemic damage would affect the expression level of &#x03B3;-enolase and quercetin might exert its protective effect by the alteration of ischemia-induced changes in &#x03B3;-enolase.</p>

<sec sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Experimental animal preparation</title>
  <p>Adult Sprague-Dawley male rats (210&#x2013;230 g, <italic>n</italic>=64) were purchased from Samtako Co (Animal Breeding Center, Osan, Korea). All experimental rats were given space with a controlled consistent temperature (25&#x2103;) and lighting environment (12 h/12 h light/dark cycle). All experimental protocols related to the use of animals were approved by the Institutional Animal Care and Use Committee at Gyeongsang National University. Animals were randomly divided into four groups as follows: vehicle&#x002B;sham, quercetin&#x002B;sham, vehicle&#x002B;middle cerebral artery occlusion (MCAO), and quercetin&#x002B;MCAO (<italic>n</italic>=13 per group). Quercetin (Sigma, St. Louis, MO, USA) was dissolved in phosphate-buffered saline containing 0.1% dimethyl sulfoxide. Quercetin (50 mg/kg) or vehicle was administered by intraperitoneal injection at 1 h before MCAO onse [<xref ref-type="bibr" rid="B20">20</xref><xref ref-type="bibr" rid="B21">21</xref><xref ref-type="bibr" rid="B22">22</xref><xref ref-type="bibr" rid="B23">23</xref>]. Vehicle only used a solvent solution without the quercetin addition.</p>
</sec>

<sec>
<title>Middle cerebral artery occlusion</title>
  <p>Animals were anaesthetized with intramuscular injection of Zoletil (50 mg/kg, Virbac, Carros, France). Animals were placed in supine position on operating table and heat pad was placed to maintain the body temperature (37&#x00B1;0.5&#x2103;) during the operation. Ventral midline of the neck skin was incised to expose the right common carotid artery (CCA) and the external carotid artery (ECA). After a careful dissociation of right CCA and right ECA from the surrounding tissues, right CCA was temporarily blocked by microvascular clipping and the right ECA was cut. A flame-rounded 4/0 monofilament was carefully inserted into the cut of the right ECA. Nylon filament was advanced 20&#x2013;22 mm from the right CCA bifurcation through the right internal carotid artery to occlude the right middle cerebral artery. Microvascular clip on the right CCA was removed carefully. After 24 h of MCAO onset, the animals were euthanized and decapitated in order to extract brain tissues.</p>
</sec>

<sec>
<title>2-Dimensional gel electrophoresis</title>
  <p>The ischemic core of right cerebral cortex was homogenized on ice for 1 min with lysis buffer (8M urea, 4% CHAPS, ampholytes and 40 mM Tris-HCl). The proteins and cellular debris were separated by centrifugation at 16,000 g for 20 min at 4&#x2103;. The supernatants were collected and the extracted protein concentration was determined using a Bradford protein assay kit (Bio-Rad, Hercules, CA, USA). Bovine serum albumin was used as a standard according to the manufacturer's instruction. Protein analysis was performed by 2-demensional gel electrophoresis. First-dimensional electrophoresis was performed through isoelectric focusing (IEF). Immobilized pH gradient (IPG) gel strips (17 cm, pH 4&#x2013;7 and pH 6&#x2013;9, Bio-Rad) containing 50 &#x00B5;g of protein sample were rehydrated for 13 h at room temperature using a sample buffer (8 M urea, 2% CHAPS, 20 mM DTT, 0.5% IPG buffer and bromophenol blue). Rehydrated strips were subjected to IEF using the Ettan IPGphor 3 System (GE Healthcare, Uppsala, Sweden) under the following conditions: 250 V for 15 min, 10,000 V for 3 h and then 10,000 to 50,000 V. Subsequently, strips were equilibrated via two steps. First step was performed in equilibration buffer [6 M urea, 30% glycerol, 2% SDS, 50 mM Tris-HCl (pH 8.8)] containing 1% DTT for 15 min and second step was processed in equilibration buffer containing 2.5% iodoacetamide for 15 min. After equilibration, strips were loaded onto SDS-polyacrylamide gradient gels (7.5&#x2013;17.5%) for second dimensional electrophoresis. Gels were electrophoresed using Protein-II XI electrophoresis equipment until bromophenol blue dye reached the bottom under the following conditions: 5 mA for 2 h, followed by 10 mA for 10 h at 10&#x2103;. After electrophoresis, the gels were fixed in the fixation solution (12% acetic acid and 50% methanol) for 2 h and then immersed in 50% ethanol for 20 min. In order to visualize the protein spots, fixed gels were stained with a silver solution (0.2% silver nitrate) for 20 min and developed with a developer (0.2% sodium carbonate). Prior to analyzing the protein spots, gels were scanned by Agfa ARCUS 1200&#x2122; and stored as image forms (Agfa-Gevaert, Mortsel, Belgium). The gel images were analyzed with PDQuest 2-D analysis software (Bio-Rad). Targeted protein spots were extracted from gels to perform a MALDI-TOF. Trypsin-containing buffer was used for a gel digestion and proteins were extracted. Mass spectrometry was conducted on a Voyager System DE-STR MALDI-TOF mass spectrometer to analyze the extracted proteins. MS-Fit and ProFound programs were used to detect mass-analyzed proteins and SWISS-prot and NCBI databases were engaged to identify protein sequences.</p>
</sec>

<sec>
<title>Western blot analysis</title>
  <p>Frozen ischemic core of right cerebral cortex was homogenized and sonicated on ice with lysis buffer [1% Triton X-100 and 1 mM EDTA in phosphate buffer saline (PBS, pH 7.4)] containing 200 &#x00B5;M phenylmethylsulfonyl fluoride. Subsequently, homogenates were centrifuged at 15,000 g for 20 min at 4&#x2103; in order to separate the soluble proteins from lysates and supernatant was collected. The protein concentration of the supernatant was measured by BCA assay kit (Pierce, Rockford, IL, USA) with bovine serum albumin as a standard. Total protein samples (30 &#x00B5;g per lane) were loaded on 10% SDS-polyacrylamide gel and electrophoresed. Separated proteins were entirely transferred to poly-vinylidene fluoride membranes (Millipore, Billerica, MA, USA). In order to prevent the non-specific antibody reaction, membranes were blocked with 5% non-fat dried milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 h. After blocking, membranes were washed with TBST and then incubated with primary antibodies: anti-&#x03B3;-enolase (diluted 1:1000, Santa Cruz Biotechnology, TX, USA) and anti-&#x03B2;-actin (1:1,000, Santa Cruz Biotechnology). Membranes were washed with TBST three times to remove non-reactive primary antibodies. Horseradish peroxidase-conjugated goat anti-rabbit IgG (1:5,000, Pierce) were treated to the membranes as secondary antibodies. Immunoreactivity was identified by applying an enhanced chemiluminescence (ECL) Western blot analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to the manufacturer's instruction. Western blot signal intensity was determined with SigmaGel 1.0 (Jandel Scientific, San Rafael, CA, USA) and SigmaPlot 4.0 (SPSS Inc., Point Richmond, CA, USA).</p>
</sec>

<sec>
<title>Reverse transcription-PCR</title>
  <p>The Ischemic core of right cerebral cortex was homogenized with Trizol Reagent (Life Technologies, Rockville, MD, USA) and then centrifugation was performed at 13,000 g for 20 min at 4&#x2103;. Total RNA was collected by isolating the supernatant of the homogenates. Total RNA samples were transcribed into single-stranded complementary DNA using the Superscript III firststrand system (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's recommendation. To amplify the targeted gene sequences of the cDNA, PCR was carried out under the following conditions: 5 min at 94&#x2103;; 30 sec at 94&#x2103;, 30 sec at 54&#x2103;, and 1 min at 72&#x2103; for 30 cycles; and 10 min at 72&#x2103;. Primer sequences for &#x03B3;-enolase and &#x03B2;-actin were 5&#x2032;-TGGATCTCCATACTGCCAAAG-3&#x2032; (forward) and 5&#x2032;-CCAACTCCTCTTCAATCCTCAT-3&#x2032; (reverse), and 5&#x2032;-GGGTCAGAAGGACTCCTACG-3&#x2032; (forward) and 5&#x2032;-GGTCTCAAACATGATCTGGG-3&#x2032; (reverse), respectively. PCR product was mixed with Loading STAR (Dyne bio, Sungnam, Korea) and loaded on 1% agarose gel for an electrophoresis. After electrophoresis, PCR product bands were visualized under the ultraviolet light. Intensity analysis of PCR product bands was carried out using SigmaGel 1.0 (Jandel Scientific, San Rafael, CA, USA) and SigmaPlot 4.0 (SPSS Inc., Point Richmond, CA, USA).</p>
</sec>

<sec>
<title>Immunofluorescence staining</title>
  <p>The brain samples were fixed in 4% paraformaldehyde in 0.1M phosphate buffered saline (PBS, pH 7.4) solution. After dehydration and clearing processes with ethyl alcohol and xylene, tissues were embedded with Paraplast (Leica, Wetzlar, Germany) and sliced into 4 &#x00B5;m thickness using rotary microtome (Leica). The sliced sections were deparaffinized in xylene and hydrated with a series of differently concentrated ethyl alcohols (100, 95, 90, 80 and 70%) and water. Hydrated sections were submersed in 0.1M sodium citrate (pH 6.0) and autoclaved for antigen retrieval steps. After cooling the slides to room temperature, sections were treated with 0.5% fetal bovine serum for the blockade of non-specific bindings. The sections were incubated overnight at 4&#x2103; with anti-&#x03B3;-enolase (1:100, Santa Cruz Biotechnology). After the primary antibody incubation, slides were rinsed with PBS and fluorescein isothiocyanate (FITC)-conjugated secondary antibody (1:100, Santa Cruz Biotechnology) was reacted for 1 h at room temperature. Slides were mounted by using UltraCruz mounting medium with 4&#x2032;,6-diamidino-2-phenylindole (DAPI, Santa Cruz Biotechnology) for DNA counterstaining and cover-slipped for microscopic evaluation. The fluorescent signal of slides was detected with a confocal microscope (FV-1000, Olympus, Tokyo, Japan) in a dark chamber and images were photographed for further data analysis. The five areas of ischemic core in right cerebral cortex were randomly selected in each animals and the number of &#x03B3;-enolase positive cells was determined using Image-Pro Plus image analysis software. The ratio of &#x03B3;-enolase positive cells was determined as the number of FITC-stained cells to the number of nuclei counterstained with DAPI.</p>
</sec>

<sec>
<title>Statistical analysis</title>
  <p>All experimental data are represented as means&#x00B1;standard error of mean (SEM). The data of each groups were compared by two-way analysis of variance (ANOVA) followed by <italic>post-hoc</italic> Scheffe's test. Differences in comparisons were considered significant at <italic>P</italic>&#x003C;0.05.</p>
</sec>
</sec>

<sec sec-type="results">
<title>Results</title>
  <p>We observed a change in &#x03B3;-enolase protein spots in response to quercetin treatment during MCAO-induced cerebral ischemia using a proteomic approach. The peptide mass of &#x03B3;-enolase was 14/70 and the sequence coverage was 34%. MCAO surgical injury induced the decrease of &#x03B3;-enolase protein expression in the cerebral cortices. However, this decrease in &#x03B3;-enolase expression by MCAO was attenuated in the presence of quercetin. &#x03B3;-Enolase protein levels were similar between vehicle- and quercetin-treated animals that underwent the sham operation (<xref ref-type="fig" rid="F1">Figure 1A</xref>). We evaluated &#x03B3;-enolase levels as the ratio of the intensity of vehicle&#x002B;sham to vehicle&#x002B;MCAO animals and quercetin&#x002B;MCAO animals, and the calculated values were 0.48&#x00B1;0.03 and 0.93&#x00B1;0.04, respectively (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Western blot and reverse transcription-PCR analyses showed changes in &#x03B3;-enolase levels in response to quercetin during MCAO injury. &#x03B3;-Enolase protein level was decreased in the MCAO-induced animals with vehicle treatment compared to the sham-operated group. Quercetin treatment alleviated the injury-induced decrease in &#x03B3;-enolase protein expression (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The normalized &#x03B3;-enolase protein levels by &#x03B2;-actin were 0.65&#x00B1;0.02 and 0.90&#x00B1;0.04 in vehicle&#x002B;MCAO animals and quercetin&#x002B;MCAO animals, respectively (<xref ref-type="fig" rid="F2">Figure 2B</xref>). &#x03B3;-Enolase transcription level was lower in the MCAO-induced animals with vehicle treatment than that of sham-operated animals, while quercetin treatment attenuated the injury-induced decrease in &#x03B3;-enolase transcription level (<xref ref-type="fig" rid="F3">Figure 3A</xref>). &#x03B3;-Enolase transcription levels were similar in both vehicle- and quercetin-treated animals with sham operation. &#x03B3;-Enolase transcription levels were 0.73&#x00B1;0.04 and 0.97&#x00B1;0.03 in vehicle&#x002B;MCAO animals and quercetin&#x002B;MCAO animals, respectively (<xref ref-type="fig" rid="F3">Figure 3B</xref>). We used immunofluorescence staining technique to visualize the effect of quercetin in &#x03B3;-enolase expression on brain tissue sections (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The number of &#x03B3;-enolase positive cells was significantly decreased in the ischemic core of cerebral cortex in vehicle&#x002B;MCAO animals compared with that of vehicle&#x002B;sham animals. However, the decrease of &#x03B3;-enolase positive cells was improved in the ischemic core of cerebral cortex in quercetin&#x002B;MCAO animals. The number of &#x03B3;-enolase positive cells was similar in both vehicle- and quercetin-treated animals with sham operation. The ratio of &#x03B3;-enolase positive cells to DAPI positive cells was 0.13&#x00B1;0.02 and 0.49&#x00B1;0.04 in vehicle&#x002B;MCAO animals and quercetin&#x002B;MCAO animals, respectively (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p>
</sec>

<sec sec-type="discussion">
<title>Discussion</title>
  <p>Quercetin has a neuroprotective effect in ischemic stroke and protects brain tissues from MCAO-induced neuronal cell injury [<xref ref-type="bibr" rid="B8">8</xref><xref ref-type="bibr" rid="B24">24</xref>]. Quercetin treatment remarkably reduces the infarct volume in a cerebral ischemia animal model and prevents neuronal cell death [<xref ref-type="bibr" rid="B25">25</xref>]. Quercetin administration during the acute phase of brain ischemia significantly induces the expression of antioxidants and reinstates the mitochondrial functions, consequently prevents the cell death [<xref ref-type="bibr" rid="B26">26</xref><xref ref-type="bibr" rid="B27">27</xref>]. This study elucidated the regulation of &#x03B3;-enolase by quercetin in focal cerebral ischemia.</p>

  <p>Enolases are very important for energy generation during glycolysis and the deterioration in enolase activity adversely affects the process of energy metabolism in brain. The overexpression of enolases promotes the growth of cultured neuronal tissues [<xref ref-type="bibr" rid="B28">28</xref><xref ref-type="bibr" rid="B29">29</xref>]. Moreover, enolase enhances neuronal survival and regenerates axonal growth, and consequently acts as a neurotrophic agent [<xref ref-type="bibr" rid="B25">25</xref><xref ref-type="bibr" rid="B26">26</xref>]. The down regulation of enolase leads to neurodegeneration and &#x03B3;-enolase has been demonstrated as a stress marker for neuronal diseases [<xref ref-type="bibr" rid="B30">30</xref>]. This study showed that &#x03B3;-enolase expression has declined after MCAO operation, while quercetin treatment prevents the injury-induced decrease of &#x03B3;-enolase. These results were confirmed by several experimental techniques including Western blot, reverse transcription-PCR, and immunofluorescence staining. &#x03B3;-Enolase is a neurotrophic factor and promotes neuronal differentiation and neurite regeneration [<xref ref-type="bibr" rid="B9">9</xref><xref ref-type="bibr" rid="B29">29</xref>]. &#x03B3;-Enolase triggers the activation of PI3K/Akt pathways and leads to neuronal cell survival [<xref ref-type="bibr" rid="B31">31</xref>]. It is reported that quercetin attenuates cell apoptosis in focal cerebral ischemia via the activation of PI3K/Akt signaling pathway [<xref ref-type="bibr" rid="B8">8</xref><xref ref-type="bibr" rid="B32">32</xref>]. Moreover, quercetin enhances exercise-mediated functional recovery after brain ischemia through up-regulation of PI3K/Akt activity and promotion of anti-oxidative and anti-apoptotic signaling pathways [<xref ref-type="bibr" rid="B33">33</xref>]. Our results clearly showed that quercetin modulates the expression level of &#x03B3;-enolase in MCAO-induced ischemic brain injury. However, further studies are needed to elicit the biochemical relation between quercetin and &#x03B3;-enolase expression. Our findings in this study suggest that quercetin attenuates the &#x03B3;-enolase reduction in ischemic brain insult and consequently prevents the neuronal cell death through the neuroprotective mechanism of quercetin. In conclusion, we propose that quercetin treatment in cerebral ischemia modulates the expression of &#x03B3;-enolase and this action mediated by quercetin might be one of the neuroprotective mechanisms contributing to neuronal cell survival.</p>
</sec>

</body>

<back>

<ack>
<title>Acknowledgments</title>
  <p>This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF-2015R1D1A1A01058270).</p>
</ack>

<fn-group>
<fn fn-type="conflict">
<label>Conflict of interests</label>
  <p>The authors declare that there is no financial conflict of interests to publish these results.</p>
</fn>
</fn-group>

<ref-list>
  <ref id="B1">
    <label>1</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Cho</surname>
          <given-names>JY</given-names>
        </name>
        <name>
          <surname>Kim</surname>
          <given-names>IS</given-names>
        </name>
        <name>
          <surname>Jang</surname>
          <given-names>YH</given-names>
        </name>
        <name>
          <surname>Kim</surname>
          <given-names>AR</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>SR</given-names>
        </name>
      </person-group>
      <article-title>Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia</article-title>
      <source>Neurosci Lett</source>
      <year>2006</year>
      <volume>404</volume>
      <issue>3</issue>
      <fpage>330</fpage>
      <lpage>335</lpage>
    </element-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Dok-Go</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>KH</given-names>
        </name>
        <name>
          <surname>Kim</surname>
          <given-names>HJ</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Song</surname>
          <given-names>YS</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>YH</given-names>
        </name>
        <name>
          <surname>Jin</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>YS</given-names>
        </name>
        <name>
          <surname>Cho</surname>
          <given-names>J</given-names>
        </name>
      </person-group>
      <article-title>Neuroprotective effects of antioxidative flavonoids, quercetin, dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntiaficus-indica var. saboten</article-title>
      <source>Brain Res</source>
      <year>2003</year>
      <volume>965</volume>
      <issue>1-2</issue>
      <fpage>130</fpage>
      <lpage>136</lpage>
    </element-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hajieva</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Bayatti</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Granold</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Behl</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Moosmann</surname>
          <given-names>B</given-names>
        </name>
      </person-group>
      <article-title>Membrane protein oxidation determines neuronal degeneration</article-title>
      <source>J Neurochem</source>
      <year>2015</year>
      <volume>133</volume>
      <issue>3</issue>
      <fpage>352</fpage>
      <lpage>367</lpage>
    </element-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Heo</surname>
          <given-names>HJ</given-names>
        </name>
        <name>
          <surname>Lee</surname>
          <given-names>CY</given-names>
        </name>
      </person-group>
      <article-title>Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration</article-title>
      <source>J Agric Food Chem</source>
      <year>2004</year>
      <volume>52</volume>
      <issue>25</issue>
      <fpage>7514</fpage>
      <lpage>7517</lpage>
    </element-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Mahesh</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Menon</surname>
          <given-names>VP</given-names>
        </name>
      </person-group>
      <article-title>Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats</article-title>
      <source>Phytother Res</source>
      <year>2004</year>
      <volume>18</volume>
      <issue>2</issue>
      <fpage>123</fpage>
      <lpage>127</lpage>
    </element-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Fiorani</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>De Sanctis</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Menghinello</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Cucchiarini</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Cellini</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Dach&#x00E0;</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells</article-title>
      <source>Free Radic Res</source>
      <year>2001</year>
      <volume>34</volume>
      <issue>6</issue>
      <fpage>639</fpage>
      <lpage>648</lpage>
    </element-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Bate</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Salmona</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Williams</surname>
          <given-names>A</given-names>
        </name>
      </person-group>
      <article-title>Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42</article-title>
      <source>J Neuroinflammation</source>
      <year>2004</year>
      <volume>1</volume>
      <issue>1</issue>
      <fpage>4</fpage>
    </element-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Ahmad</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Khan</surname>
          <given-names>MM</given-names>
        </name>
        <name>
          <surname>Hoda</surname>
          <given-names>MN</given-names>
        </name>
        <name>
          <surname>Raza</surname>
          <given-names>SS</given-names>
        </name>
        <name>
          <surname>Khan</surname>
          <given-names>MB</given-names>
        </name>
        <name>
          <surname>Javed</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Ishrat</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Ashafaq</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Ahmad</surname>
          <given-names>ME</given-names>
        </name>
        <name>
          <surname>Safhi</surname>
          <given-names>MM</given-names>
        </name>
        <name>
          <surname>Islam</surname>
          <given-names>F</given-names>
        </name>
      </person-group>
      <article-title>Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion</article-title>
      <source>Neurochem Res</source>
      <year>2011</year>
      <volume>36</volume>
      <issue>8</issue>
      <fpage>1360</fpage>
      <lpage>1371</lpage>
    </element-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Schmechel</surname>
          <given-names>DE</given-names>
        </name>
        <name>
          <surname>Brightman</surname>
          <given-names>MW</given-names>
        </name>
        <name>
          <surname>Marangos</surname>
          <given-names>PJ</given-names>
        </name>
      </person-group>
      <article-title>Neurons switch from non-neuronal enolase to neuron-specific enolase during differentiation</article-title>
      <source>Brain Res</source>
      <year>1980</year>
      <volume>190</volume>
      <issue>1</issue>
      <fpage>195</fpage>
      <lpage>214</lpage>
    </element-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Ueta</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Nagasawa</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Oyabu-Manabe</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Toida</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Ishimura</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Hori</surname>
          <given-names>H</given-names>
        </name>
      </person-group>
      <article-title>Localization of enolase in synaptic plasma membrane as an alphagamma heterodimer in rat brain</article-title>
      <source>Neurosci Res</source>
      <year>2004</year>
      <volume>48</volume>
      <issue>4</issue>
      <fpage>379</fpage>
      <lpage>386</lpage>
    </element-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Rider</surname>
          <given-names>CC</given-names>
        </name>
        <name>
          <surname>Taylor</surname>
          <given-names>CB</given-names>
        </name>
      </person-group>
      <article-title>Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties</article-title>
      <source>Biochim Biophys Acta</source>
      <year>1974</year>
      <volume>365</volume>
      <issue>1</issue>
      <fpage>285</fpage>
      <lpage>300</lpage>
    </element-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Lamand&#x00E9;</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Mazo</surname>
          <given-names>AM</given-names>
        </name>
        <name>
          <surname>Lucas</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Montarras</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Pinset</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Gros</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Legault-Demare</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Lazar</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Murine muscle-specific enolase: cDNA cloning, sequence, and developmental expression</article-title>
      <source>Proc Natl Acad Sci U S A</source>
      <year>1989</year>
      <volume>86</volume>
      <issue>12</issue>
      <fpage>4445</fpage>
      <lpage>4449</lpage>
    </element-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Schmechel</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Marangos</surname>
          <given-names>PJ</given-names>
        </name>
        <name>
          <surname>Zis</surname>
          <given-names>AP</given-names>
        </name>
        <name>
          <surname>Brightman</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Goodwin</surname>
          <given-names>FK</given-names>
        </name>
      </person-group>
      <article-title>Brain enolases as specific markers of neuronal and glial cells</article-title>
      <source>Science</source>
      <year>1978</year>
      <volume>199</volume>
      <issue>4326</issue>
      <fpage>313</fpage>
      <lpage>315</lpage>
    </element-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Marangos</surname>
          <given-names>PJ</given-names>
        </name>
        <name>
          <surname>Schmechel</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Parma</surname>
          <given-names>AM</given-names>
        </name>
        <name>
          <surname>Clark</surname>
          <given-names>RL</given-names>
        </name>
        <name>
          <surname>Goodwin</surname>
          <given-names>FK</given-names>
        </name>
      </person-group>
      <article-title>Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue</article-title>
      <source>J Neurochem</source>
      <year>1979</year>
      <volume>33</volume>
      <issue>1</issue>
      <fpage>319</fpage>
      <lpage>329</lpage>
    </element-citation>
  </ref>

  <ref id="B15">
    <label>15</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Meric</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Gunduz</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Turedi</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Cakir</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Yandi</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>The prognostic value of neuron-specific enolase in head trauma patients</article-title>
      <source>J Emerg Med</source>
      <year>2010</year>
      <volume>38</volume>
      <issue>3</issue>
      <fpage>297</fpage>
      <lpage>301</lpage>
    </element-citation>
  </ref>

  <ref id="B16">
    <label>16</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Gonz&#x00E1;lez-Garc&#x00ED;a</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Gonz&#x00E1;lez-Quevedo</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Fern&#x00E1;ndez-Concepci&#x00F3;n</surname>
          <given-names>O</given-names>
        </name>
        <name>
          <surname>Pe&#x00F1;a-S&#x00E1;nchez</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Men&#x00E9;ndez-Sa&#x00ED;nz</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Hern&#x00E1;ndez-D&#x00ED;az</surname>
          <given-names>Z</given-names>
        </name>
        <name>
          <surname>Arteche-Prior</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Pando-Cabrera</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Fern&#x00E1;ndez-Novales</surname>
          <given-names>C</given-names>
        </name>
      </person-group>
      <article-title>Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients</article-title>
      <source>Clin Biochem</source>
      <year>2012</year>
      <volume>45</volume>
      <issue>16-17</issue>
      <fpage>1302</fpage>
      <lpage>1307</lpage>
    </element-citation>
  </ref>

  <ref id="B17">
    <label>17</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hay</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Royds</surname>
          <given-names>JA</given-names>
        </name>
        <name>
          <surname>Davies-Jones</surname>
          <given-names>GA</given-names>
        </name>
        <name>
          <surname>Lewtas</surname>
          <given-names>NA</given-names>
        </name>
        <name>
          <surname>Timperley</surname>
          <given-names>WR</given-names>
        </name>
        <name>
          <surname>Taylor</surname>
          <given-names>CB</given-names>
        </name>
      </person-group>
      <article-title>Cerebrospinal fluid enolase in stroke</article-title>
      <source>J Neurol Neurosurg Psychiatry</source>
      <year>1984</year>
      <volume>47</volume>
      <issue>7</issue>
      <fpage>724</fpage>
      <lpage>729</lpage>
    </element-citation>
  </ref>

  <ref id="B18">
    <label>18</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Cronberg</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Rundgren</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Westhall</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Englund</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Siemund</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Ros&#x00E9;n</surname>
          <given-names>I</given-names>
        </name>
        <name>
          <surname>Widner</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Friberg</surname>
          <given-names>H</given-names>
        </name>
      </person-group>
      <article-title>Neuron-specific enolase correlates with other prognostic markers after cardiac arrest</article-title>
      <source>Neurology</source>
      <year>2011</year>
      <volume>77</volume>
      <issue>7</issue>
      <fpage>623</fpage>
      <lpage>630</lpage>
    </element-citation>
  </ref>

  <ref id="B19">
    <label>19</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Steinhoff</surname>
          <given-names>BJ</given-names>
        </name>
        <name>
          <surname>Tumani</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Otto</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Mursch</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Wiltfang</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Herrendorf</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Bittermann</surname>
          <given-names>HJ</given-names>
        </name>
        <name>
          <surname>Felgenhauer</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Paulus</surname>
          <given-names>W</given-names>
        </name>
        <name>
          <surname>Markakis</surname>
          <given-names>E</given-names>
        </name>
      </person-group>
      <article-title>Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy</article-title>
      <source>Epilepsy Res</source>
      <year>1999</year>
      <volume>36</volume>
      <issue>1</issue>
      <fpage>75</fpage>
      <lpage>82</lpage>
    </element-citation>
  </ref>

  <ref id="B20">
    <label>20</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Pu</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Mishima</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Irie</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Motohashi</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Tanaka</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Orito</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Egawa</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Kitamura</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Egashira</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Iwasaki</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Fujiwara</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats</article-title>
      <source>J Pharmacol Sci</source>
      <year>2007</year>
      <volume>104</volume>
      <issue>4</issue>
      <fpage>329</fpage>
      <lpage>334</lpage>
    </element-citation>
  </ref>

  <ref id="B21">
    <label>21</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Dong</surname>
          <given-names>YS</given-names>
        </name>
        <name>
          <surname>Wang</surname>
          <given-names>JL</given-names>
        </name>
        <name>
          <surname>Feng</surname>
          <given-names>DY</given-names>
        </name>
        <name>
          <surname>Qin</surname>
          <given-names>HZ</given-names>
        </name>
        <name>
          <surname>Wen</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Yin</surname>
          <given-names>ZM</given-names>
        </name>
        <name>
          <surname>Gao</surname>
          <given-names>GD</given-names>
        </name>
        <name>
          <surname>Li</surname>
          <given-names>C</given-names>
        </name>
      </person-group>
      <article-title>Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage</article-title>
      <source>Int J Med Sci</source>
      <year>2014</year>
      <volume>11</volume>
      <issue>3</issue>
      <fpage>282</fpage>
      <lpage>290</lpage>
    </element-citation>
  </ref>

  <ref id="B22">
    <label>22</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Li</surname>
          <given-names>X</given-names>
        </name>
        <name>
          <surname>Wang</surname>
          <given-names>H</given-names>
        </name>
        <name>
          <surname>Gao</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Li</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Tang</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Wen</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Yang</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Zhuang</surname>
          <given-names>Z</given-names>
        </name>
        <name>
          <surname>Zhou</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Mao</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Fan</surname>
          <given-names>Y</given-names>
        </name>
      </person-group>
      <article-title>Quercetin induces mitochondrial biogenesis in experimental traumatic brain injury via the PGC-1&#x03B1; signaling pathway</article-title>
      <source>Am J Transl Res</source>
      <year>2016</year>
      <volume>8</volume>
      <issue>8</issue>
      <fpage>3558</fpage>
      <lpage>3566</lpage>
    </element-citation>
  </ref>

  <ref id="B23">
    <label>23</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Lin</surname>
          <given-names>X</given-names>
        </name>
        <name>
          <surname>Lin</surname>
          <given-names>CH</given-names>
        </name>
        <name>
          <surname>Zhao</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Zuo</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Ye</surname>
          <given-names>Z</given-names>
        </name>
        <name>
          <surname>Liu</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Lin</surname>
          <given-names>MT</given-names>
        </name>
      </person-group>
      <article-title>Quercetin protects against heat stroke-induced myocardial injury in male rats: Antioxidative and antiinflammatory mechanisms</article-title>
      <source>Chem Biol Interact</source>
      <year>2017</year>
      <volume>265</volume>
      <fpage>47</fpage>
      <lpage>54</lpage>
    </element-citation>
  </ref>

  <ref id="B24">
    <label>24</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Ghosh</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Sarkar</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Mandal</surname>
          <given-names>AK</given-names>
        </name>
        <name>
          <surname>Das</surname>
          <given-names>N</given-names>
        </name>
      </person-group>
      <article-title>Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats</article-title>
      <source>PLoS One</source>
      <year>2013</year>
      <volume>8</volume>
      <issue>4</issue>
      <elocation-id>e57735</elocation-id>
    </element-citation>
  </ref>

  <ref id="B25">
    <label>25</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Annapurna</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Ansari</surname>
          <given-names>MA</given-names>
        </name>
        <name>
          <surname>Manjunath</surname>
          <given-names>PM</given-names>
        </name>
      </person-group>
      <article-title>Partial role of multiple pathways in infarct size limiting effect of quercetin and rutin against cerebral ischemia-reperfusion injury in rats</article-title>
      <source>Eur Rev Med Pharmacol Sci</source>
      <year>2013</year>
      <volume>17</volume>
      <issue>4</issue>
      <fpage>491</fpage>
      <lpage>500</lpage>
    </element-citation>
  </ref>

  <ref id="B26">
    <label>26</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Rogerio</surname>
          <given-names>AP</given-names>
        </name>
        <name>
          <surname>Kanashiro</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Fontanari</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>da Silva</surname>
          <given-names>EV</given-names>
        </name>
        <name>
          <surname>Lucisano-Valim</surname>
          <given-names>YM</given-names>
        </name>
        <name>
          <surname>Soares</surname>
          <given-names>EG</given-names>
        </name>
        <name>
          <surname>Faccioli</surname>
          <given-names>LH</given-names>
        </name>
      </person-group>
      <article-title>Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma</article-title>
      <source>Inflamm Res</source>
      <year>2007</year>
      <volume>56</volume>
      <issue>10</issue>
      <fpage>402</fpage>
      <lpage>408</lpage>
    </element-citation>
  </ref>

  <ref id="B27">
    <label>27</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Ansari</surname>
          <given-names>MA</given-names>
        </name>
        <name>
          <surname>Abdul</surname>
          <given-names>HM</given-names>
        </name>
        <name>
          <surname>Joshi</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Opii</surname>
          <given-names>WO</given-names>
        </name>
        <name>
          <surname>Butterfield</surname>
          <given-names>DA</given-names>
        </name>
      </person-group>
      <article-title>Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease</article-title>
      <source>J Nutr Biochem</source>
      <year>2009</year>
      <volume>20</volume>
      <issue>4</issue>
      <fpage>269</fpage>
      <lpage>275</lpage>
    </element-citation>
  </ref>

  <ref id="B28">
    <label>28</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Takei</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Kondo</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Nagaike</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Ohsawa</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Kato</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Kohsaka</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>Neuronal survival factor from bovine brain is identical to neuron-specific enolase</article-title>
      <source>J Neurochem</source>
      <year>1991</year>
      <volume>57</volume>
      <issue>4</issue>
      <fpage>1178</fpage>
      <lpage>1184</lpage>
    </element-citation>
  </ref>

  <ref id="B29">
    <label>29</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hattori</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Takei</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Mizuno</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Kato</surname>
          <given-names>K</given-names>
        </name>
        <name>
          <surname>Kohsaka</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain</article-title>
      <source>Neurosci Res</source>
      <year>1995</year>
      <volume>21</volume>
      <issue>3</issue>
      <fpage>191</fpage>
      <lpage>198</lpage>
    </element-citation>
  </ref>

  <ref id="B30">
    <label>30</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hafner</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Obermajer</surname>
          <given-names>N</given-names>
        </name>
        <name>
          <surname>Kos</surname>
          <given-names>J</given-names>
        </name>
      </person-group>
      <article-title>&#x03B3;-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways</article-title>
      <source>Biochem J</source>
      <year>2012</year>
      <volume>443</volume>
      <issue>2</issue>
      <fpage>439</fpage>
      <lpage>450</lpage>
    </element-citation>
  </ref>

  <ref id="B31">
    <label>31</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Parnetti</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Palumbo</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Cardinali</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Loreti</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Chionne</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Cecchetti</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Senin</surname>
          <given-names>U</given-names>
        </name>
      </person-group>
      <article-title>Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia</article-title>
      <source>Neurosci Lett</source>
      <year>1995</year>
      <volume>183</volume>
      <issue>1-2</issue>
      <fpage>43</fpage>
      <lpage>45</lpage>
    </element-citation>
  </ref>

  <ref id="B32">
    <label>32</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Yao</surname>
          <given-names>RQ</given-names>
        </name>
        <name>
          <surname>Qi</surname>
          <given-names>DS</given-names>
        </name>
        <name>
          <surname>Yu</surname>
          <given-names>HL</given-names>
        </name>
        <name>
          <surname>Liu</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Yang</surname>
          <given-names>LH</given-names>
        </name>
        <name>
          <surname>Wu</surname>
          <given-names>XX</given-names>
        </name>
      </person-group>
      <article-title>Quercetin attenuates cell apoptosis in focal cerebral ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling pathway</article-title>
      <source>Neurochem Res</source>
      <year>2012</year>
      <volume>37</volume>
      <issue>12</issue>
      <fpage>2777</fpage>
      <lpage>2786</lpage>
    </element-citation>
  </ref>

  <ref id="B33">
    <label>33</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Chang</surname>
          <given-names>HC</given-names>
        </name>
        <name>
          <surname>Yang</surname>
          <given-names>YR</given-names>
        </name>
        <name>
          <surname>Wang</surname>
          <given-names>PS</given-names>
        </name>
        <name>
          <surname>Wang</surname>
          <given-names>RY</given-names>
        </name>
      </person-group>
      <article-title>Quercetin enhances exercise-mediated neuroprotective effects in brain ischemic rats</article-title>
      <source>Med Sci Sports Exerc</source>
      <year>2014</year>
      <volume>46</volume>
      <issue>10</issue>
      <fpage>1908</fpage>
      <lpage>1916</lpage>
    </element-citation>
  </ref>
</ref-list>

</back>

<floats-group>

<fig position="float" id="F1">
<label>Figure 1</label>
<caption>
  <title>&#x03B3;-Enolase protein spots identified by MALDI-TOF in the vehicle&#x002B;sham, quercetin&#x002B;sham, vehicle&#x002B;middle cerebral artery occlusion (MCAO), and quercetin&#x002B;MCAO animals. Squares indicate the &#x03B3;-enolase protein spots (A). The intensity of spots was measured using PDQuest software (B). The ratio of intensity is described as spots intensity of these animals to spots intensity of sham&#x002B;vehicle animals. Data (<italic>n</italic>=4) are shown as mean&#x00B1;SEM. <sup>*</sup><italic>P</italic>&#x003C;0.05.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lar-33-308-g001"></graphic>
</fig>

<fig position="float" id="F2">
<label>Figure 2</label>
<caption>
  <title>Western blot analysis of &#x03B3;-enolase protein levels in the vehicle&#x002B;sham, quercetin&#x002B;sham, vehicle&#x002B;middle cerebral artery occlusion (MCAO), and quercetin&#x002B;MCAO animals. Each lane represents an individual animal (A). Densitometric analysis is represented as intensity of &#x03B3;-enolase to intensity of &#x03B2;-actin (B). Data (<italic>n</italic>=4) are shown as mean&#x00B1;SEM. <sup>*</sup><italic>P</italic>&#x003C;0.05.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lar-33-308-g002"></graphic>
</fig>

<fig position="float" id="F3">
<label>Figure 3</label>
<caption>
  <title>Reverse transcription-PCR analysis of &#x03B3;-enolase protein levels in the vehicle&#x002B;sham, quercetin&#x002B;sham, vehicle&#x002B;middle cerebral artery occlusion (MCAO), and quercetin&#x002B;MCAO animals. Each lane represents an individual animal (A). Densitometric analysis is represented as intensity of &#x03B3;-enolase to intensity of &#x03B2;-actin (B). Data (<italic>n</italic>=4) are shown as mean&#x00B1;SEM. <sup>*</sup><italic>P</italic>&#x003C;0.05.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lar-33-308-g003"></graphic>
</fig>

<fig position="float" id="F4">
<label>Figure 4</label>
<caption>
  <title>Images of double immunofluorescence labeling with &#x03B3;-enolase (green color) and DAPI (nuclei marker, blue) in the ischemic core of cerebral cortex in vehicle&#x002B;sham, quercetin&#x002B; sham, vehicle&#x002B;middle cerebral artery occlusion (MCAO), and quercetin&#x002B;MCAO animals (A). Quantitative assessment of &#x03B3;-enolase positive neurons in ischemic core of rat cerebral cortex (B). The arrows indicate the &#x03B3;-enolase positive cells. Data (n=4) are shown as mean&#x00B1;SEM.<sup>*</sup><italic>P</italic>&#x003C;0.05. Scale bars=100 &#x00B5;m.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="lar-33-308-g004"></graphic>
</fig>

</floats-group>

</article>